A close-up on doxorubicin binding to γ-cyclodextrin: an elucidating spectroscopic, photophysical and conformational study

被引:52
作者
Anand, Resmi [1 ]
Ottani, Stefano [1 ]
Manoli, Francesco [1 ]
Manet, Ilse [1 ]
Monti, Sandra [1 ]
机构
[1] CNR, ISOF, I-40129 Bologna, Italy
关键词
METHYL-BETA-CYCLODEXTRIN; HOST-GUEST INTERACTIONS; DRUG-DELIVERY SYSTEMS; IN-VITRO; MOLECULAR-DYNAMICS; ANTHRACYCLINE ANTIBIOTICS; ANTITUMOR-ACTIVITY; CARRIER SYSTEM; DAUNORUBICIN; COMPLEXATION;
D O I
10.1039/c2ra01221a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The association of doxorubicin (DOX) with gamma-cyclodextrin (gamma-CyD) was studied in phosphate buffer of pH 7.4, at 22 degrees C by performing titration experiments monitored with circular dichroism (CD), UV-vis absorption, and fluorescence. Global analysis of multiwavelength spectroscopic data obtained at different DOX concentrations was performed by taking into account the DOX monomer-dimer equilibrium. Formation of gamma-CyD: DOX 1 : 1, 2 : 1, 1 : 2 and 2 : 2 complexes was evidenced. The stability constants and the absolute CD, UV-vis absorption and fluorescence spectra of all the complexes were determined. gamma-CyD did not prove to be able to disrupt the DOX dimer when the latter is the predominant form in solution. The triplet state absorption and kinetic properties of DOX in the presence of gamma-CyD and in ethanol were also determined by laser flash photolysis. The excited singlet and the triplet features indicated the environment experienced by DOX in the CyD complexes is ethanol-like. The structure of the gamma-CyD: DOX 1 : 1 complex was investigated by Molecular Mechanics (MM) and Molecular Dynamics (MD) for both the neutral and the positively charged (-NH3+ in the daunosamine moiety) DOX forms. The possibility of interaction of both the aglycone and the daunosamine parts with the gamma-CyD cavity was evidenced.
引用
收藏
页码:2346 / 2357
页数:12
相关论文
共 54 条
[1]   Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry [J].
Agrawal, Prashansa ;
Barthwal, Sudhir Kumar ;
Barthwal, Ritu .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (04) :1437-1451
[2]   Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line [J].
Al-Omar, A ;
Abdou, S ;
De Robertis, L ;
Marsura, A ;
Finance, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) :1115-1120
[3]   TRIPLET-STATE CHARACTERISTICS AND SINGLET OXYGEN GENERATION PROPERTIES OF ANTHRACYCLINES [J].
ANDREONI, A ;
LAND, EJ ;
MALATESTA, V ;
MCLEAN, AJ ;
TRUSCOTT, TG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 990 (02) :190-197
[4]  
[Anonymous], HDB PHOTOCHEMISTRY
[5]  
[Anonymous], [No title captured], Patent No. 091
[6]   EFFECT OF CYCLODEXTRIN COMPLEXATION ON THE CHEMICAL-STABILITY OF DOXORUBICIN AND DAUNORUBICIN IN AQUEOUS-SOLUTIONS [J].
BEKERS, O ;
BEIJNEN, JH ;
VIS, BJ ;
SUENAGA, A ;
OTAGIRI, M ;
BULT, A ;
UNDERBERG, WJM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 72 (02) :123-130
[7]   INCLUSION COMPLEXATION OF DOXORUBICIN AND DAUNORUBICIN WITH CYCLODEXTRINS [J].
BEKERS, O ;
BEIJNEN, JH ;
OTAGIRI, M ;
BULT, A ;
UNDERBERG, WJM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :671-674
[8]   INCLUSION COMPLEX-FORMATION OF ANTHRACYCLINE ANTIBIOTICS WITH CYCLODEXTRINS - A PROTON NUCLEAR-MAGNETIC-RESONANCE AND MOLECULAR MODELING STUDY [J].
BEKERS, O ;
KETTENESVANDENBOSCH, JJ ;
VANHELDEN, SP ;
SEIJKENS, D ;
BEIJNEN, JH ;
BULT, A ;
UNDERBERG, WJM .
JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1991, 11 (02) :185-193
[9]   Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation:: preparation, characterization and in vitro evaluation [J].
Betancourt, Tania ;
Brown, Brandon ;
Brannon-Peppas, Lisa .
NANOMEDICINE, 2007, 2 (02) :219-232
[10]   Recent advances and future directions in amphiphilic cyclodextrin nanoparticles [J].
Bilensoy, Erem ;
Hincal, A. Atilla .
EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (11) :1161-1173